| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.35 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.28 | 0.4 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.001 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0007 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.17 | 0.4 |